Abstract
Background
A previous report confirmed the safety of laparoscopy-assisted total and proximal gastrectomies (LATG and LAPG) (JCOG1401). This report demonstrates the 5-year relapse-free survival (RFS) and overall survival (OS) after long-term follow-up to confirm the efficacy of these surgical methods as key secondary endpoints for cStage I gastric cancer.
Methods
This study enrolled patients who had histologically proven gastric adenocarcinoma and were diagnosed with clinical T1N0, T1N(+), or T2N0 tumors according to the 14th edition of the Japanese Classification of Gastric Carcinoma (3rd English edition).
Results
Between April 2015 and February 2017, 246 patients were enrolled, although one patient was excluded because of misregistration. Meticulous follow-up was continued for > 5 years for each patient, and the data were analyzed in March 2022. The 5-year RFS was 90.0% (95% confidence interval [CI] 85.5–93.2%), and the 5-year OS was 91.2% (95% CI 86.9–94.2%) in all enrolled patients. Grade 3 or 4 late postoperative complications were detected in 12.7% of patients.
Conclusions
This single-arm study showed that the long-term outcomes of LATG/LAPG for cStage I gastric cancer were acceptable, which is considered one of the standard treatments when performed by experienced surgeons.
Trail registration UMIN000017155 (http://www.umin.ac.jp/ctr/).
Similar content being viewed by others
References
Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4:16–148.
Yano H, Monden T, Kinuta M, Nakano Y, Tono T, Matsui S, et al. The usefulness of laparoscopy-assisted distal gastrectomy in comparison ith that of open distal gastrctomy for early gastric cancer. Gastric Cancer. 2001;4:93–7.
Uyama I, Sugioka A, Fujita J, Komori Y, Matsui H, Soga R, et al. Completely laparoscopic extraperigastric lymph node dissection for gastric malignancies located in the middle or lower third of the stomach. Gastric Cancer. 1999;2:186–90.
Lee JH, Han H, Lee JH. A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results. Surg Endosc. 2005;19:168–73.
Kunisaki C, Makino H, Takagawa R, Oshima T, Nagano Y, Ono HA, et al. Efficacy of laparoscopy-assited distal gastrectomy for gastric cancer in the elderly. Surg Endosc. 2009;23:377–83.
Berrospi F, Celis J, Ruíz E, Payet E, Chávez I, Young F. Laparoscopic distal gastrectomy for gastric cancer: initial experience. Rev Gastroenterol Peru. 2008;28:119–24.
Katai H, Sasako M, Fukuda H, Nakamura K, Hiki N, Saka M, et al. Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for cStage I gastric cancer: a multicenter phase II trial (JCOG 0703). Gastric Cancer. 2010;13:238–44.
Hiki N, Katai H, Mizusawa J, Nakamura K, Nakamori M, Yoshikawa T, et al. Long-term outcomes of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for cStage I gastric cancer: a multicenter phase II trial (JCOG0703). Gastric Cancer. 2018;21:155–61.
Katai H, Mizusawa J, Katayama H, Takagi M, Yoshikawa T, Fukagawa T, et al. Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for cStage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912. Gastric Cancer. 2017;20:699–708.
Katai H, Mizusawa J, Katayama H, Morita S, Yamada T, Bando E, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for cStage IA or IB gastric cancer (JCOG0912): a multicentre, noninferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5:142–51.
Kim HH, Han SU, Kim MC, Kim W, Kee HJ, Ryu SW, et al. Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: the KLASS-01 randomized clinical trial. JAMA Oncol. 2019;5:506–13.
Japanese Gastric Cancer Association. Gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer. 2023;26:1–25.
Mochiki E, Toyomasu Y, Ogata K, Andoh H, Ohno T, Aihara R, et al. Laparoscopically assisted total gastrectomy with lymph node dissection for upper and middle gastric cancer. Surg Endosc. 2008;22:1997–2002.
Ahn SH, Lee JH, Park DJ, Kim HH. Comparative study of clinical outcomes between laparoscopy-assisted proximal gastrectomy (LAPG) and laparoscopy-assisted total gastrectomy (LATG) for proximal gastric cancer. Gastric Cancer. 2013;16:282–9.
Katai H, Mizusawa J, Katayama H, Kunisaki C, Sakuramoto S, Inaki N, et al. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for cStage I gastric cancer: Japan Clinical Oncology Group study JCOG1401. Gastric Cancer. 2019;22:999–1008.
Japanese Gastric Cancer A. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver.4). Classification of gastric carcinoma. Gastric Cancer. 2017;20:1–19.
Institute NC. Common terminology criteria for adverse events (CTCAE) version 4.0. Bethesda: National Cancer Institute; 2015.
Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien–Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.
Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, et al. Surgical outcomes for early gastric cancer in the upper third of the stomach. J Am Coll Surg. 2005;200:15–9.
Lu J, Yoon C, Xu B, Xie J, Li P, Zheng C, et al. long-term survival after minimally invasive versus open gastrectomy for gastric adenocarcinoma: a propensity score-matched analysis of patients in the United States and China. Ann Surg Oncol. 2020;27:802–11.
Kinoshita T, Akimoto E, Yura M, Yoshida M. Survival outcomes of laparoscopic versus open total gastrectomy with nodal dissection for gastric cancer in a high-volume Japanese center: a propensity score-matched analysis. Ann Gastroenterol Surg. 2023;7:53–62.
Yang Y, Chen Y, Hu Y, Feng Y, Mao Q, Xue W. Outcomes of laparoscopic versus open total gastrectomy with D2 lymphadenectomy for gastric cancer: a systematic review and meta-analysis. Eur J Med Res. 2022;27:124.
Suzuki S, Takahashi A, Ishikawa T, Akazawa K, Katai H, Isobe Y, et al. Registration Committee of the Japanese Gastric Cancer Association. Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry. Gastric Cancer. 2021;24(5):45–566.
Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, et al. Significance of long-term follow-up of early gastric cancer. Ann Surg Oncol. 2006;13:363–9.
Zhao BW, Chen YM, Jiang SS, Chen YB, Zhou ZW, Li YF. Lymph node metastasis, a unique independent prognostic factor in early gastric cancer. PLoS ONE. 2015;10:e0129531.
Hosoda K, Yamashita K, Katada N, Moriya H, Mieno H, Shibata T, et al. Potential benefits of laparoscopy-assisted proximal gastrectomy with esophagogastrostomy for cT1 upper-third gastric cancer. Surg Endosc. 2016;30:3426–36.
Jung DH, Lee Y, Kim DW, Park YS, Ahn SH, Park DJ, et al. Laparoscopic proximal gastrectomy with double tract reconstruction is superior to laparoscopic total gastrectomy for proximal early gastric cancer. Surg Endosc. 2017;31:3961–9.
Pan T, Galiullin D, Chen XL, Zhang WH, Yang K, Liu K, et al. Incidence of adhesive small bowel obstruction after gastrectomy for gastric cancer and its risk factors: a long-term retrospective cohort study from a high-volume institution in China. Updates Surg. 2021;73:615–26.
Suzuki S, Kosugi S, Kuwabara S, Ueki K, Oka Y, Nishimaki T, et al. Tumor recurrence in patients with early gastric cancer: a clinicopathologic evaluation. J Exp Clin Cancer Res. 1998;17:187–91.
Youn HG, An JY, Choi MG, Noh JH, Sohn TS, Kim S. Recurrence after curative resection of early gastric cancer. Ann Surg Oncol. 2010;17:448–54.
Hyung WJ, Yang HK, Han SU, Lee YJ, Park JM, Kim JJ, et al. A feasibility study of laparoscopic total gastrectomy for cStage I gastric cancer: a prospective multi-center phase II clinical trial, KLASS 03. Gastric Cancer. 2019;22:214–22.
Liu F, Huang C, Xu Z, Su X, Zhao G, Ye J, et al. Morbidity and mortality of laparoscopic vs open total gastrectomy for cStage I gastric cancer the CLASS02 multicenter randomized clinical trial. JAMA Oncol. 2020;6:1590–7.
Funding
This study was supported in part by the National Cancer Center Research and Development Funds (26-A-4, 29-A-3,2020-J-3, 2023-J-03), Grant-in-Aid for Clinical Cancer Research H26-053, and AMED under Grant numbers JP18ck0106317 and JP15ck0106056.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard
All procedures performed in studies involving human participants were in accordance with the clinical standards of the institutional and /or national research committee with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kunisaki, C., Katai, H., Sakuramoto, S. et al. A nonrandomized controlled trial: long-term outcomes of LATG/LAPG for cStage I gastric cancer: Japan Clinical Oncology Group Study JCOG1401. Gastric Cancer 27, 164–175 (2024). https://doi.org/10.1007/s10120-023-01432-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10120-023-01432-y